Peptide Purity Testing Explained: Area-Percent, Net Peptide Content, and Why They Differ

A 99% purity figure and the amount of peptide in a vial are two different measurements. Here is how peptide purity testing works, what area-percent purity and net peptide content each mean, and why the gap between them is normal.

For laboratory research use only. 21+.

"99% pure" is the most quoted number in the research peptide world. It is also one of the most misunderstood. Many buyers read it as "99% of the powder in this vial is peptide." That is not what it means, and the difference matters if you are preparing materials for quantitative lab work.

Peptide purity testing actually produces two different kinds of number: area-percent purity and net peptide content. This guide explains both, how each is measured, and why a lot can be 99% pure and still contain noticeably less than its nominal amount of peptide, with nothing wrong at all.

Two questions, two numbers

Area-percent purity Net peptide content
Question it answers Of the peptide-like material, how much is the target sequence? Of the total powder mass, how much is peptide?
Typical method HPLC with UV detection Amino acid analysis, nitrogen analysis, or mass balance
Typical research-grade figure 95–99%+ Often well below 100% (varies by sequence and salt form)
What it ignores Water, counterions, salts, anything UV-invisible Which peptide species is present

Both are useful. Neither replaces the other.

Area-percent purity (the HPLC number)

High-performance liquid chromatography (HPLC) separates a dissolved sample into its components, which leave the column at different times. A UV detector, usually set around 210–220 nm where the peptide backbone absorbs, records a peak for each one.

Area-percent purity is the area of the main peak divided by the total area of all detected peaks. If the main peak accounts for 99% of the total peak area, the purity is reported as 99%.

The minor peaks are usually peptide-related impurities from synthesis: chains missing one amino acid (deletion sequences), chains that stopped early (truncations), or chains carrying leftover protecting groups. Some come from storage, such as oxidized or deamidated forms of the target.

What area-percent does not see:

  • Water. Freeze-dried powder always holds some residual moisture.
  • Counterions. Peptides are salts. The charged groups on the chain are paired with counterions such as trifluoroacetate (TFA), acetate or chloride.
  • Inorganic material. Salts and metals don't absorb at peptide wavelengths.

So area-percent purity is a statement about the peptide fraction of the sample, relative to other UV-visible components. It is not a statement about mass.

Net peptide content (the mass number)

Net peptide content (sometimes "peptide content" or "assay") is the share of the powder's total mass that is actually peptide. The rest is mostly water and counterions.

It can be measured in a few ways:

  • Amino acid analysis. The peptide is broken down into its amino acids, which are measured and used to calculate how much peptide was present.
  • Nitrogen content. Total nitrogen is measured and converted to a peptide amount using the sequence.
  • Mass balance. Everything that is not the target peptide is measured separately and subtracted.

Why counterions matter so much

Most research peptides are made by solid-phase synthesis. Trifluoroacetic acid is used to cleave the finished chain from the resin and as an ion-pairing reagent during HPLC purification, so peptides commonly come out as TFA salts. A 2025 study from ETH Zurich describes exactly this, notes that TFA salts are reported to interfere with biological assays, validates several methods for measuring residual TFA, and argues that the counterion should be quantified and specified whenever synthetic peptides are used in assays (Erckes et al., Pharmaceuticals, 2025; DOI: 10.3390/ph18081163).

The counterion can be measured directly. A comparison of ion chromatography, capillary isotachophoresis and capillary electrophoresis for acetate, trifluoroacetate and chloride in synthetic peptides found ion chromatography performed best (Mrozik et al., Journal of Peptide Science, 2012; DOI: 10.1002/psc.1436).

A peptide with many basic residues carries many positive charges, so it pairs with many counterions. That makes its counterion share of the mass larger, and its net peptide content lower, even at identical HPLC purity.

A worked example from the literature

The clearest published illustration comes from metrology, where purity has to be traceable to the SI units. Scientists at China's National Institute of Metrology assigned a purity value to a synthetic peptide by mass balance (Wang et al., Journal of Pharmaceutical and Biomedical Analysis, 2022; DOI: 10.1016/j.jpba.2021.114401). They measured:

  • 21 structurally related peptide impurities (including deamidated and oxidized forms and amino acid insertions) by LC with high-resolution tandem mass spectrometry, each ranging from 0.05 to 15.65 mg per gram;
  • water by coulometric Karl Fischer titration;
  • non-volatile counterions by ion chromatography;
  • inorganic elements by ICP-MS;
  • volatile organic compounds by headspace GC-MS.

The assigned value was 796.5 mg of peptide per gram of material, with an uncertainty of 6.5 mg/g. In other words, about 80% of a carefully characterized, high-quality material was the target peptide. The other ~20% was impurities, water, counterions and trace components. The method was verified in an international key comparison coordinated by the Bureau International des Poids et Mesures.

That is the gap this article is about. It is normal. It is chemistry, not a defect.

How reference-standard labs handle it

The United States Pharmacopeial Convention (USP), writing with the UK medicines regulator, describes a two-step process for assigning a value to a peptide reference standard: first a mass balance approach assigns a quantitative value to the bulk peptide, then that bulk material is used as a standard to assign a value to the final lyophilized vial (McCarthy et al., Pharmaceutical Research, 2023; DOI: 10.1007/s11095-023-03493-1). The paper also covers content uniformity between vials and stability studies. Research-grade materials aren't characterized to that standard, but the logic is the same: purity and content are separate measurements.

What this means when you read a label

A vial labeled "10 mg" may mean 10 mg of powder or 10 mg of peptide, depending on the supplier's convention. Our companion piece on reading a peptide label covers this in detail. Related reading: Reading a Peptide Label: What "10 mg" Means (and Doesn't).

When you read a COA, look for:

  1. HPLC purity with the chromatogram and the method.
  2. Identity by mass spectrometry.
  3. Net peptide content, if reported, and the method used.
  4. Counterion identity and amount (for example "TFA content: X%").
  5. Water content (for example "Water (KF): X%").

If only HPLC purity is shown, you know the peptide fraction is clean. You don't know how much of the powder is peptide. For quantitative work, that is worth asking about.

Common misreadings

  • "99% pure means 99% of the mass is peptide." No. It means 99% of the UV-visible signal came from the main peak.
  • "Low net peptide content means the product is bad." Not necessarily. A heavily charged peptide can have a modest net content at excellent purity.
  • "Two lots at 98% are interchangeable." Their net content can still differ if water or counterion levels differ.
  • "A higher purity number is always better." Only if the methods are comparable. Different columns, gradients and wavelengths can give different area-percent figures for the same material.

How Seratide reports it

Each Seratide lot is linked to a record on the Lot lookup page, laid out with HPLC purity against specification, identity by LC-MS, and endotoxin. The records there today are clearly labeled layout samples that show the format, with placeholder values; issued laboratory reports replace them as lots are analyzed. For a refresher on peptide structure, see our peptide basics page.

Sources

All sources below were opened and their PubMed abstracts read on 2026-09-29. Claims are limited to what the abstracts state.

  1. Erckes V, et al. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel). 2025;18(8):1163. PubMed: https://pubmed.ncbi.nlm.nih.gov/40872554/ · DOI: https://doi.org/10.3390/ph18081163
  2. Mrozik W, et al. Determination of counter-ions in synthetic peptides by ion chromatography, capillary isotachophoresis and capillary electrophoresis. J Pept Sci. 2012;18(3):192-8. PubMed: https://pubmed.ncbi.nlm.nih.gov/22252914/ · DOI: https://doi.org/10.1002/psc.1436
  3. Wang S, et al. Mass balance method for SI-traceable purity assignment of synthetic oxytocin. J Pharm Biomed Anal. 2022;207:114401. PubMed: https://pubmed.ncbi.nlm.nih.gov/34656934/ · DOI: https://doi.org/10.1016/j.jpba.2021.114401
  4. McCarthy D, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023;40(6):1317-1328. PubMed: https://pubmed.ncbi.nlm.nih.gov/36949371/ · DOI: https://doi.org/10.1007/s11095-023-03493-1

For laboratory research use only.